IFNA1 and myeloid sarcoma: IFN signaling (and also “PD-1 signaling”, downstream of type I and type II IFNs24) was again identified as a commonly upregulated pathway between “T1D and AD”, “MS and AD”, and “MS and T1D” (Figures 3F–3H).